Alvotech Files June 2024 Report on Form 6-K
Ticker: ALVOW · Form: 6-K · Filed: Jun 7, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 6 |
| Reading Time | 8 min |
| Key Dollar Amounts | $965.0 million, $900.0 million, $65.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Alvotech filed its June 6-K, confirming 20-F reporting and Luxembourg HQ.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on June 7, 2024, to report its activities for the month of June 2024. The filing indicates that Alvotech is a foreign private issuer and will file its annual reports under cover of Form 20-F. The company is incorporated in Luxembourg and its principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Why It Matters
This filing provides routine updates on Alvotech's corporate activities as a foreign private issuer, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 9, Rue de Bitbourg, L-1273 Luxembourg (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- Form 6-K (company) — Filing type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant has made or is required to make public pursuant to the laws of its home country, or has filed or is required to file with a stock exchange, or has distributed or is required to distribute to its security holders.
What is Alvotech's SEC File Number?
Alvotech's SEC File Number is 001-41421.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg.
Does Alvotech file its annual reports under Form 20-F or Form 40-F?
Alvotech indicates it files its annual reports under cover of Form 20-F.
What is the SIC code for Alvotech?
Alvotech's Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 1,887 words · 8 min read · ~6 pages · Grade level 20 · Accepted 2024-06-07 08:35:09
Key Financial Figures
- $965.0 million — nts in an aggregate principal amount of $965.0 million (the “Term Facility”), of w
- $900.0 million — “Term Facility”), of which $900.0 million will be drawable as “first out&rd
- $65.0 million — “First Out Term Loans”) and $65.0 million will be drawable as “second out&r
Filing Documents
- f6k_060624.htm (6-K) — 20KB
- exh_991.htm (EX-99.1) — 12KB
- 0001171843-24-003336.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: June 7, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel